13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-16, with 47 holding rows worth $977,072,000.
- Accession
- 0001425738-16-000037
- Filer
- CIK 1425738
- Filed
- 2016-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2016
A holdings report, 47 entries on the cover page, a total value of $977,072,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $977,072,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 10,718,420 | $90,571,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 1,786,599 | $82,148,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 3,099,336 | $59,507,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 1,267,967 | $58,326,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 19,150,650 | $56,494,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,320,192 | $47,263,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 2,275,765 | $43,308,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 478,287 | $39,449,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 970,121 | $34,042,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 1,053,018 | $33,760,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 114,448 | $30,675,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 1,056,059 | $29,358,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 470,549 | $28,972,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 1,863,035 | $28,355,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,332,520 | $25,065,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 1,428,931 | $22,691,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 191,625 | $21,529,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 329,013 | $21,218,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 2,468,847 | $20,640,000 | thousands by filing date | |
| MODEL N INC | 607525102 | COM | 1,885,359 | $20,305,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 889,607 | $18,148,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,238,273 | $16,963,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 1,180,887 | $16,674,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 216,594 | $15,697,000 | thousands by filing date | |
| VCA ANTECH INC | 918194101 | COM | 207,800 | $11,988,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464900 | CALL | 600,000 | $11,520,000 | thousands by filing date | call |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 729,699 | $9,413,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 876,088 | $8,682,000 | thousands by filing date | |
| CONFORMIS INC | 20717E101 | COM | 792,355 | $8,518,000 | thousands by filing date | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 109,806 | $8,339,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 130,571 | $7,346,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 660,129 | $6,753,000 | thousands by filing date | |
| HEARTWARE INTL INC | 422368100 | COM | 214,771 | $6,748,000 | thousands by filing date | |
| PRESS GANEY HOL | 74113L102 | Common Stock | 218,214 | $6,564,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 82,300 | $5,938,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 421,742 | $3,960,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 123,800 | $3,669,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 263,000 | $3,503,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 4,000,000 | $3,220,000 | thousands by filing date | principal |
| DURECT CORP | 266605104 | COM | 2,327,137 | $3,142,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 552,713 | $2,697,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,486,980 | $2,677,000 | thousands by filing date | |
| ISHARES TR | 464288828 | US HLTHCR PR ETF | 4,520 | $551,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 27,055 | $488,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 10,000 | $115,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 19,710 | $58,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 10,000 | $25,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001425738-16-000037 | this filing | 2016-05-16 | acceptance time not in the bulk data set |